Key result
Insulin resistance linked to ~10% higher apoptotic EMPs in non-diabetic chronic HF.
Observational (n=300)
Yes
Insulin resistance is a significant predictor for increased apoptotic-derived endothelial microparticles in non-diabetic patients with chronic heart failure.
Answers are grounded in this paper and cite their sources.
Association should not yet change practice in non-diabetic HF; leaves open whether insulin resistance drives endothelial microparticle release.
Background: The causality role of different immune phenotype in IR developing among Chronic Heart Failure (CHF) subjects has not determined obviously.The aim of the study was to assess relationship between IR and immune phenotype of circulating endothelial-derived microparticles (EMPs) in patients with CHF. Methods:The study retrospectively involved 300 CHF patients aged 48 to 62 years who were undergone multispiral computed tomography angiography or coronary angiography.All the patients have given written informed consent for participation in the study.Biomarkers were measured at baseline of the study.Results: These were not significant differences between both cohort patients in EMPs labeled as CD144+/CD31+, CD144+/annexin V+, and CD62E+ microparticles.Higher concentrations of CD144+/CD31+/annexin V+ EMPs and CD31+/annexin V+ EMPs were found in IR subjects when compared with none IR patients.Using multivariate logistic regression analyses, we found that HOMA-IR (OR=1.14, 95% CI=1.08-1.21,P=0.001), NT-proBNP (OR=1.07,95% CI=1.04-1.10,P=0.001), hs-CRP (OR=1.04,95% CI=1.02-1.07,P=0.001), and NYHA class (OR=1.03,95% CI=1.01-1.05,P=0.001) were predictors for increased CD31+/ annexin V+ EMPs.Therefore, HOMA-IR (OR=1.10,95% CI=1.05-1.17,P=0.001), NT-proBNP (OR=1.08,95% CI=1.04-1.12,P=0.001), and NYHA class (OR=1.05,95% CI=1.02-1.09,P=0.001) significantly predicted elevation of CD144+/CD31+/annexin V+ EMPs.Using C-statistics for Models with HOMA-IR, NYHA class, and circulating biomarkers (hs-CRP, NT-proBNP) as Continuous Variables we found that adding of combination of these biomarkers to the based model constructed with HOMA-IR did not improve the relative IDI for increased CD144+/CD31+/annexin V+ and CD31+/annexin V+ microparticles.When we used other model constructed on entering variables, IDI avoids to be improved for increased CD144+/CD31+/annexin V+ and CD31+/annexin V+ microparticles. Conclusion:We found that IR remains statistically significant predictor for increased apoptotic-derived EMPs labelled as CD144+/CD31+/annexin V+ and CD31+/ annexin V+ EMPs in none-diabetic patients with CHF patients and that these findings reflect exiting impaired phenotype of circulating EMPs in this patient population.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted an observational in Chronic Heart Failure (n=300). Insulin resistance vs. Non-insulin resistance was evaluated on Elevation of CD144+/CD31+/annexin V+ EMPs (OR 1.10, 95% CI 1.05-1.17, p=0.001). Insulin resistance was a significant independent predictor for increased apoptotic-derived endothelial microparticles labeled as CD144+/CD31+/annexin V+ and CD31+/annexin V+ in non-diabetic patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: